CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...
Phase 3
Portland, Oregon, United States and 17 other locations
of hypercortisolism in a population with difficult to control type 2 diabetes (T2D) (hemoglobin A1c ≥7.5%) despite receiving standard-of-car...
Phase 4
Portland, Oregon, United States and 35 other locations
The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...
Phase 2
Portland, Oregon, United States and 42 other locations
purpose of this study is to evaluate the effectiveness and safety of the RIGHTEST Continuous Monitoring (CGM) System in adult population with diabetes...
Portland, Oregon, United States and 12 other locations
weight in adult participants with obesity or overweight and type 2 diabetes. The study will last about 77 weeks and may include up to 22 vis...
Phase 3
Portland, Oregon, United States and 138 other locations
This study will look at how much CagriSema helps participants with type 2 diabetes lower their blood sugar and body weight. CagriSema is a n...
Phase 3
Portland, Oregon, United States and 48 other locations
decrease in the kidneys' ability to work properly, and type 1 diabetes.In people with type 1 diabetes, the body does not make enoug...
Phase 3
Portland, Oregon, United States and 84 other locations
fenofibrate is effective for reducing the onset of proliferative diabetic retinopathy (PDR) or and the results are adopted by the community ...
Phase 3
Portland, Oregon, United States and 60 other locations
This study is open to adults with diabetic retinopathy. People who have non-proliferative diabetic retinopathy of moderate or high ...
Phase 2
Portland, Oregon, United States and 23 other locations
The main purpose of this study is to determine safety and efficacy of orforglipron compared with insulin glargine in participants with type 2 diabetes...
Phase 3
Portland, Oregon, United States of America and 395 other locations
Clinical trials
Research sites
Resources
Legal